# Regeneron expects 2027 R&D expense to rise by a mid-teens percentage while recording a $1B Sanofi upfront payment in Q4

- Source: Seeking Alpha Market Currents
- Published: 2026-10-30T18:40:17+00:00
- Category: Markets
- Original: https://seekingalpha.com/news/4661640-regeneron-expects-2027-r-and-d-expense-to-rise-by-a-mid-teens-percentage-while-recording-a-1b?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
- Canonical: https://groundlevelnews.com/story/regeneron-expects-2027-r-d-expense-to-rise-by-a-mid-teens-percentage-w-899e12/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents._
